ArticleThe Canadian journal of urology2025
Implementation of opioid-reduced protocols after penile prosthesis surgery.
Article in The Canadian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain management after penile prosthesis (PP) has traditionally required opioid medication. Recently, urologic prosthetic surgeons have sought to establish opioid-free protocols (OFP) and/or opioid-reduced protocols (ORP) for PP postoperative pain management. We sought to investigate the adoption patterns of OFP/ORP among surgeons who perform PP surgery and identify barriers to implementation.
methodsA 13-question confidential survey was sent to members of the Sexual Medicine Society of North America (SMSNA) and the Society of Urologic Prosthetic Surgeons (SUPS) via email. The survey was administered via Qualtrics. A t-test was used to analyze survey responses.
resultsThe survey was fully completed by 53 respondents. Approximately 51% (27/53) of respondents performed more than 30 implants annually. OFPs were used at least some of the time by 43% (23/53) of respondents, with 9.5% (5/53) exclusively using OFPs. In comparison, 83% (44/53) of respondents used an ORP at least some of the time, and 32% (17/53) exclusively used ORP. Of the non-opioid medications/techniques used, acetaminophen was the most common (96%, 51/53), followed by nonsteroidal anti-inflammatory drugs (NSAIDs) (92%, 49/53) and dorsal penile block (77%, 41/53). At the time of discharge, 75% (40/53) of respondents prescribed fewer than 10 doses of opioid medication, and 15% (8/53) did not prescribe any opioids. The majority of respondents using ORP/OFP were extremely satisfied (70%, 33/47), and none of the respondents were either somewhat or extremely dissatisfied.
conclusionOur study demonstrates that opioid-reduced/opioid-free regimens are widely adopted among the prosthetic urologic community. These protocols limit narcotic exposure to protect patients from adverse events related to opioids.
Indexed as
Identifiers
41496539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.